RecruitingNCT05860699

Cannabidiol or placebo during inpatient alcohol withdrawal care

About this title

Medication studyAges 18–75FranceAddiction

The study in practice

Understand this study

Listed age limits: 18 years to 75 years.

Listed locations: Créteil and 11 more locationsSee all locations and recruitment
Study phase: Phase 2

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: April 8, 2024

Recruitment status: Recruiting
Enrollment listed in the registry: 210
Sponsor: Assistance Publique - Hôpitaux de Paris
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 2
Locations: France
Age range: From 18 Years to 75 Years
Official registry ID: NCT05860699
Official title: Show the full official title
Cannabidiol as an add-on Treatment During Inpatient Alcohol Cessation in Patients With Severe Alcohol Use Disorder: A Phase II Trial

Recruiting

Créteil · Clamart · Clermont-Ferrand

5 more locations

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Assistance Publique - Hôpitaux de Paris.

Does this study involve medication?

Yes. The study involves medication, including Placebo, Half dose CBD and Full dose CBD.

Who can participate?

Listed age limits: 18 years to 75 years.

Is this study still recruiting?

The registry lists this study as recruiting.